A carregar...
Efficacy, patterns of use and cost of Pertuzumab in the treatment of HER2+ metastatic breast cancer in Singapore: The National Cancer Centre Singapore experience
BACKGROUND: Pertuzumab is a humanized anti-human epidermal growth factor receptor 2 (HER2) monoclonal antibody found in a Phase III clinical trial to significantly improve median survival in HER2 positive metastatic breast cancer (MBC) when used in combination with a taxane and Trastuzumab, and its...
Na minha lista:
| Publicado no: | World J Clin Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7103528/ https://ncbi.nlm.nih.gov/pubmed/32257845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v11.i3.143 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|